What Zywie does

Zywie Inc. is a private medtech company founded in 2015 and headquartered in Johns Creek, Georgia, that develops and operates a remote cardiac monitoring platform built around three integrated components: the ZywieNano MCT patch and Zywie Clarus wearable biosensors for continuous ECG capture, the ZywiePro cloud-based software platform for data aggregation and clinician reporting, and the proprietary ZywieAI algorithm for automated arrhythmia detection. The ZywieNano patch is a miniaturized, Band-Aid-sized FDA-approved device that transmits heart rhythm data in near real time via cellular connectivity (delivered through a partnership with AT&T) for monitoring periods of up to 30 days. The ZywieAI algorithm analyzes beat-by-beat ECG signals to detect atrial fibrillation, ventricular tachycardia, bradycardia, ectopic beats, and other arrhythmias, with FDA 510(k) Class II clearance and peer-reviewed validation in journals including JACC.

Zywie operates as a CMS-approved Independent Diagnostic Testing Facility (IDTF) and serves healthcare providers — primarily cardiology practices, electrophysiologists, hospitals, and health systems — through an enterprise field sales motion staffed by Territory Managers and Field Sales Support Specialists. Pricing is quote-based rather than publicly disclosed, and revenue is generated through subscription/recurring per-study MCT services, hardware sales of the wearable patches, and managed services sold to federal customers (VA and DoD) via GSA FSS and DLA ECAT contract vehicles through channel partner Lovell Government Services. Clinical operations are distributed across Walnut Creek, California; Panama City, Florida; and Franklin, Tennessee, alongside the Johns Creek corporate headquarters. The company is led by founders Latha Ganeshan (CEO) and Sameer Adumala (CTO), with Chief Medical Officer Alok Gambhir (an electrophysiologist from Columbia University) and executives drawn from Stryker, Equifax, Cisco, LexisNexis, and Alere Health. Early-stage backers include eLab Solutions and Datum Software; no funding rounds are publicly disclosed.

Name

Zywie

Legal name

Zywie Inc.

Website

https://zywie.healthcare

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

11–50 employees

Short description

Zywie is a private medtech company that provides FDA-cleared remote cardiac monitoring via its ZywieNano wearable patch, ZywieAI arrhythmia-detection algorithm, and ZywiePro cloud platform, serving cardiologists, hospitals, health systems, and VA/DoD customers through enterprise field sales and government contracts.

Ownership category

akta.pro rank

Product category

Remote Cardiac Monitoring

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Cardiac Monitoring (ECG/Holter/Event/Patch, Loop Recorders) (HLAHACAB)

akta.pro secondary industries

Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration) (HLACAPAI), Chronic Disease Management IoT (Diabetes, CHF, COPD, Hypertension) (HLACAPAD), Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity) (HLALAFAA)

Keywords

• Remote cardiac monitoring
• Wearable ECG monitoring
• AI arrhythmia detection
• Mobile cardiac telemetry
• Cardiac monitoring services

Headquarters

HQ city

Duluth

HQ country

United States

HQ region

North America

Offices4 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure, Supply Chain

Revenue model

1. Mobile Cardiac Telemetry (MCT) Services: Continuous ECG monitoring services for 30-day periods, with near real-time data transmission and physician-reviewed analysis. Revenue generated through per-study or subscription-based arrangements with healthcare providers and health systems.
2. Wearable Device Sales: Sale of ZywieNano patches and related monitoring hardware to healthcare providers and directly to patients. Devices are provided as part of the monitoring service or sold separately for use with the cloud platform.
3. Government Contracts: Revenue from federal government customers through GSA contract vehicles (FSS, ECAT) for VA and DoD healthcare facilities.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Core offering

Zywie provides a remote cardiac monitoring platform combining the ZywieNano MCT Patch (an FDA-cleared, Band-Aid-sized wearable biosensor that live-transmits continuous ECG data for up to 30 days), the ZywieAI proprietary algorithm (FDA-approved AI for automated arrhythmia detection including AF, VT, PVC, PAC, bradycardia, and tachycardia), and the ZywiePro cloud-based monitoring platform with near real-time data access, comprehensive reporting within 1-3 business days, and EMR integration. Services include 24/7 patient concierge support, monitoring center oversight by cardiac technicians, and clinical workflow support for cardiology practices, hospitals, health systems, and government healthcare customers (VA/DoD).

Product overview

Zywie offers a unified remote cardiac monitoring platform consisting of three integrated components: (1) ZywiePro hardware (ZywieNano Patch and Zywie Clarus wearable biosensors) for continuous ECG capture, (2) ZywiePro software/cloud platform powered by the ZywieAI algorithm for arrhythmia detection and near real-time data analysis, and (3) ZywiePro services providing monitoring center oversight, EMR integration, and clinical support. The ZywieNano Patch is the flagship miniaturized wearable device—no bigger than a Band-Aid—that captures cardiac data for up to 30 days with live-transmitting capability. The ZywieAI proprietary algorithm analyzes beat-by-beat ECG data to detect arrhythmias including AF, VT, PVC, bradycardia, and tachycardia.

Differentiator

Problem solved

Functional benefit

Brands

• ZywiePro: Comprehensive cardiac remote monitoring solution combining hardware (wearable biosensor), software (cloud-based analytics and reporting), and services (monitoring support and EMR integration).
• ZywieNano Patch
• ZywieAI
• Zywie Clarus

Products and services

• ZywiePro Solution Comprehensive next-generation cardiac remote monitoring platform combining wearable biosensor hardware, cloud-based analytics software powered by the ZywieAI algorithm, and monitoring support services. Enables physicians to view cardiac events faster and in greater detail on any device with near real-time data access throughout the monitoring period and seamless EMR integration. Sold to cardiologists, electrophysiologists, hospitals, and health systems.
• ZywieNano MCT Patch Miniaturized biosensor wearable cardiac monitoring patch, no bigger than a Band-Aid. FDA-approved wearable heart monitor that is water-resistant and live-transmits every heartbeat to the cloud for analysis. Supports up to 30 days of continuous monitoring with easy reapplication and live data transmission to the ZywiePro cloud platform.
• Zywie Clarus Wearable cardiac monitoring device approved on government contract vehicles (Federal Supply Schedule and DLA ECAT). Listed alongside the ZywieNano Patch for government healthcare customers including VA and DoD healthcare facilities.
• Patient Monitoring Kit Complete monitoring kit including the Zywie patch/sensor, a phone for data transmission, charging case, adhesive patches, and prepaid return shipping. The patient wears the monitor for the prescribed monitoring period as part of the ZywiePro remote cardiac monitoring service.

Quantifiable outcome

• 16-28% higher detection of first AF, pause, and ventricular tachycardia compared to 14-day monitors when using 30-day monitoring
• +3 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability8 records

Feature5 records

Partnerships

Two partnerships are on record, tiered core.

• AT&TcoreTechnology or IntegrationAT&T provides cellular connectivity for Zywie's cardiac remote monitoring system, enabling secure, near real-time delivery of patient ECG data from the ZywiePro device to healthcare providers.
• Lovell Government ServicescoreChannel Partner/ Reseller/ DistributorLovell Government Services serves as Zywie's Service-Disabled Veteran-Owned Small Business (SDVOSB) vendor in the federal space, representing Zywie for VA and DoD sales. Enabled listing on GSA contract vehicles (FSS, ECAT).

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• iRhythm Technologies: Direct competitor offering the Zio long-duration cardiac monitoring patch and AI-driven ECG analytics. Closely comparable business model (wearable patch + cloud analytics + IDTF services) targeting the same cardiology and electrophysiology customer base as Zywie.
• Preventice Solutions (Boston Scientific): BodyGuardian line of wearable cardiac monitors (MCT, event, Holter) for arrhythmia detection, now owned by Boston Scientific. Directly competes with Zywie in the MCT and extended Holter categories serving cardiology practices and health systems.
• Bardy Diagnostics (Baxter): Maker of the CAM (Cardiac Ambulatory Monitor) patch, now part of Baxter. Provides long-duration ECG patch monitoring with focus on arrhythmia detection — highly comparable technology and customer set to ZywieNano.
• ReactDx: Independent cardiac monitoring service provider offering MCT, event monitoring, and Holter services with IDTF capabilities. Directly comparable service-based business model targeting the same cardiology customer base as Zywie.
• Medicomp: Long-standing cardiac event monitoring and MCT provider offering the Tele-Atric and SAVI monitoring services. Comparable as an IDTF-style cardiac monitoring competitor to Zywie with deep cardiology relationships.
• ScottCare Cardiovascular Solutions: Provides Holter, event, and MCT monitoring systems including the TeleSense ambulatory ECG platform. Comparable in offering wearable cardiac monitoring devices and analytical software to cardiology practices.

Emerging players

• VitalConnect: Wearable biosensor company offering the VitalPatch for continuous cardiac and multi-parameter monitoring, including arrhythmia detection. Comparable in miniaturized patch form factor and cloud analytics, with broader vital-signs ambitions beyond cardiology.

Broad incumbents

• BioTel (Philips): Cardiac monitoring service (formerly BioTel, now part of Philips) offering MCT, Holter, and event monitoring with national reach. Overlaps with Zywie in MCT and extended Holter but operates as part of a much larger portfolio of diagnostic and monitoring services.
• Boston Scientific: Global medical device conglomerate owning the Preventice cardiac monitoring franchise. Competes with Zywie across both electrophysiology capital equipment and remote monitoring services, with substantially greater scale and capital.
• Philips (Cardiac Monitoring): Provides a broad portfolio of cardiac monitoring, diagnostic, and telehealth solutions, including acquired BioTel and other remote monitoring assets. Comparable category competitor with vastly greater sales coverage and enterprise contracts.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/zywiehealthcare
• LinkedInlinkedin.com/company/zywie-inc-

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Zywie